Qube Research & Technologies LTD Vincerx Pharma, Inc. Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.57 - $6.6 $1,409 - $16,321	-2,473 Reduced 99.84%	4 $0
Q1 2024 May 14, 2024	BUY	$1.07 - $8.06 $2,646 - $19,932	2,473 Added 61825.0%	2,477 $12,000
Q3 2023 Nov 13, 2023	BUY	$0.66 - $1.38 $2 - $5	4 New	4 $0
Q3 2022 Nov 14, 2022	SELL	$0.0 - $1.72 $0 - $4,210	-2,448 Reduced 14.13%	14,878 $21,000
Q2 2022 Aug 15, 2022	BUY	$0.0 - $0.0 $0 - $0	17,326 New	17,326 $23,000

11M

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $6.57M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.